SEC Form 4 · accession 0001144204-16-074666
REPROS THERAPEUTICS INC. · RPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Joseph Podolski
Officer — President and CEO · Director
Period of report
Jan 6, 2016
Accepted (ET)
Jan 7, 2016 · 4:44 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000897075
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 6, 2016 | P | 8,177 | $1.199 | A | 73,922 | D | |
| Common StockF1 | Jan 7, 2016 | P | 3,500 | $1.14 | A | 77,422 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F175 shares are owned by certain family members of the reporting person.